374
Views
15
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Improved survival using an intensive, pediatric-based chemotherapy regimen in adults with T-cell acute lymphoblastic leukemia

, , , , , , & show all
Pages 61-65 | Received 02 Jun 2009, Accepted 04 Oct 2009, Published online: 17 Dec 2009

References

  • Boucheix C, David B, Sebban C, et al Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). French Group on Therapy for Adult Acute Lymphoblastic Leukemia. Blood 1994;84:1603–1612.
  • Uckun FM, Reaman G, Steinherez PG, et al Improved clinical outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: a Children's Cancer Group Study. Leuk Lymphoma 1996;24:57–70.
  • Huguet F, Leguay T, Raffoux E, et al Pediatric-inspired therapy in adults with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRAALL-2003 study. J Clin Oncol 2009;27:911–918.
  • Storring JM, Minden MD, Kao S, et al Treatment of adults with BCR-ABL1 negative acute lymphoblastic leukemia with a modified pediatric regimen. Br J Haematol 2009;146:76–85.
  • Al Khabori M, Samiee S, Fung S, et al Adult precursor T-lymphoblastic leukemia/lymphoma with myeloid-associated antigen expression is associated with a lower complete remission rate following induction chemotherapy. Acta Haematol 2008;120:5–10.
  • Stewart K, Keating A, Sutton D, et al Adult acute lymphoblastic leukaemia: the value of therapy intensification. Leuk Lymphoma 1991;4:103–110.
  • Kantarjian H, Thomas D, O'Brien S, et al Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer 2004;101:2788–2801.
  • Rowe JM, Buck G, Burnett AK, et al Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood 2005;106:3760–3767.
  • Gupta V, Yi Q-L, Brandwein J, et al The role of allogeneic bone marrow transplantation in adult patients below the age of 55 years with acute lymphoblastic leukemia in first complete remission: a donor vs. no donor comparison. Bone Marrow Transplant 2004;33:397–404.
  • Barry E, DeAngelo DJ, Neuberg D, et al Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols. J Clin Oncol 2007;25:813–819.
  • Greenwood MJ, Seftel MD, Richardson C, et al Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia. Leuk Lymphoma 2006;47:1245–1252.
  • Burger B, Zimmermann M, Mann G, et al Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol 2003;21:184–188.
  • Lazarus HM, Richards SM, Chopra R, et al Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993. Blood 2006;108:465–472.
  • Boissel N, Auclerc M-F, Lheritier V, et al Should Adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 Trials. J Clin Oncol 2003;21:774–780.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.